VolitionRx Limited Proceeds from (Repayments of) Other Long-term Debt
VolitionRx Limited (VNRX) reported Proceeds from (Repayments of) Other Long-term Debt of -$1.27 million for the 12-month period ending 2022-12-31, per its 10-K filed 2023-03-15.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromRepaymentsOfOtherLongTermDebt · last filed 2023-03-15
- VolitionRx Limited proceeds from (repayments of) other long-term debt for the quarter ending 2022-12-31 was -$326.53K.
- VolitionRx Limited proceeds from (repayments of) other long-term debt for the quarter ending 2022-09-30 was -$310.19K.
- VolitionRx Limited proceeds from (repayments of) other long-term debt for the quarter ending 2022-06-30 was -$380.96K.
- VolitionRx Limited proceeds from (repayments of) other long-term debt for the quarter ending 2022-03-31 was -$250.71K.
- VolitionRx Limited proceeds from (repayments of) other long-term debt for fiscal 2022 was -$1.27M.
- VolitionRx Limited proceeds from (repayments of) other long-term debt for fiscal 2021 was -$755.72K.
- VolitionRx Limited proceeds from (repayments of) other long-term debt for fiscal 2020 was -$545.39K.
- VolitionRx Limited proceeds from (repayments of) other long-term debt for fiscal 2019 was -$351.01K.
| Period end | Proceeds from (Repayments of) Other Long-term Debt 3 month | Proceeds from (Repayments of) Other Long-term Debt 6 month | Proceeds from (Repayments of) Other Long-term Debt 9 month | Proceeds from (Repayments of) Other Long-term Debt 12 month |
|---|---|---|---|---|
| 2022-12-31 | -$326.53K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-15 | -$636.72K derived: sum of 2 quarters · filed 2023-03-15 | -$1.02M derived: sum of 3 quarters · filed 2023-03-15 | -$1.27M 10-K · filed 2023-03-15 |
| 2022-09-30 | -$310.19K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | -$691.15K derived: sum of 2 quarters · filed 2022-11-14 | -$941.86K 10-Q · filed 2022-11-14 | -$1.13M derived: sum of 4 quarters · filed 2023-03-15 |
| 2022-06-30 | -$380.96K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-10 | -$631.67K 10-Q · filed 2022-08-10 | -$815.77K derived: sum of 3 quarters · filed 2023-03-15 | -$1.00M derived: sum of 4 quarters · filed 2023-03-15 |
| 2022-03-31 | -$250.71K 10-Q · filed 2022-05-11 | -$434.82K derived: sum of 2 quarters · filed 2023-03-15 | -$622.65K derived: sum of 3 quarters · filed 2023-03-15 | -$844.71K derived: sum of 4 quarters · filed 2023-03-15 |
| 2021-12-31 | -$184.10K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-15 | -$371.94K derived: sum of 2 quarters · filed 2023-03-15 | -$593.99K derived: sum of 3 quarters · filed 2023-03-15 | -$755.72K 10-K · filed 2023-03-15 |
| 2021-09-30 | -$187.83K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | -$409.89K derived: sum of 2 quarters · filed 2022-11-14 | -$571.62K 10-Q · filed 2022-11-14 | -$760.30K derived: sum of 4 quarters · filed 2022-11-14 |
| 2021-06-30 | -$222.06K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-10 | -$383.78K 10-Q · filed 2022-08-10 | -$572.47K derived: sum of 3 quarters · filed 2022-08-10 | -$695.00K derived: sum of 4 quarters · filed 2022-08-10 |
| 2021-03-31 | -$161.73K 10-Q · filed 2022-05-11 | -$350.42K derived: sum of 2 quarters · filed 2022-05-11 | -$472.94K derived: sum of 3 quarters · filed 2022-05-11 | -$591.23K derived: sum of 4 quarters · filed 2022-05-11 |
| 2020-12-31 | -$188.69K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-30 | -$311.22K derived: sum of 2 quarters · filed 2022-03-30 | -$429.50K derived: sum of 3 quarters · filed 2022-03-30 | -$545.39K 10-K · filed 2022-03-30 |
| 2020-09-30 | -$122.53K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-10 | -$240.82K derived: sum of 2 quarters · filed 2021-11-10 | -$356.70K 10-Q · filed 2021-11-10 | -$445.05K derived: sum of 4 quarters · filed 2021-11-10 |
| 2020-06-30 | -$118.29K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-11 | -$234.17K 10-Q · filed 2021-08-11 | -$322.52K derived: sum of 3 quarters · filed 2021-08-11 | |
| 2020-03-31 | -$115.88K 10-Q · filed 2021-05-11 | -$204.23K derived: sum of 2 quarters · filed 2021-05-11 | ||
| 2019-12-31 | -$88.35K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-22 | -$351.01K 10-K · filed 2021-03-22 | ||
| 2019-09-30 | -$262.66K 10-Q · filed 2020-11-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |